FDA Issues Post Operative Recommendations for Women with Transvaginal Placement of Surgical Mesh for

FDA Issues Post Operative Recommendations for Women with Transvaginal Placement of Surgical Mesh for Pelvic Organ Prolapse Ennis & Ennis, P.A. Outlines FDA’s Transvaginal Mesh Device Recommendations (PRWEB) August 04, 2011 On July 13, the U.S. Food and Drug Administration (FDA) updated an advisory on vaginal mesh implants reporting that there is little evidence that the implants improve pelvic organ prolapse and that patients are exposed to a number of risks and complications, which are not rare. According to Ennis & Ennis, P.A., the FDA then issued a Safety Communication, which
Contributor
About
PRWeb, a leader in online news and press release distribution, has been used by attorneys, law firms and more than 40,000 organizations